1.Forman D, Martel CD, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat
J, Ferlay J, Bray F, Plummer M: Global Burden of Human Papillomavirus and Related Diseases. Vaccine 2012, 30(Suppl 5):F12-F23.
2.Freddie B, Jian-Song R, Eric M, Jacques F: Global estimates of cancer prevalence for 27 sites in the adult population in 2008. International Journal of Cancer Journal International Du Cancer 2013, 132(5):1133-1145.
3.Shi JF, Qiao YL, Smith JS, Dondog B, Bao YP, Dai M, Clifford GM, Franceschi S: Epidemiology and prevention of human papillomavirus and cervical cancer in China and
Mongolia. Vaccine 2008, 26(1):M53-M59.
4.Mu?Oz N, ., Bosch FX, Sanjosé S, De, Tafur L, ., Izarzugaza I, ., Gili M, ., Viladiu
P, ., Navarro C, ., Martos C, ., Ascunce N, . The causal link between human papillomavirus and invasive cervical cancer: a population-based
case-control study in Colombia and Spain. International Journal of Cancer 2010, 52(5):743-749.
5.Koutsky LA: Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007, 356(19):1915-1927.
6.Hausen HZ: Papillomaviruses in Human Cancers. Molecular Carcinogenesis 2010, 111(6):581-587.
7.Nubia MO, F Xavier B, Silvia DS, Rolando H, Xavier C, Shah KV, Snijders PJF, Meijer
CJLM: Epidemiologic classification of human papillomavirus types associated with cervical
cancer. N Engl J Med 2003.
8.Peng G, Rebecca HJ, Ni L, Laia B, Silvia DS, Silvia F, Clifford GM: Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical
infection to cancer. International Journal of Cancer 2012, 131(10):2349-2359.
9.Zeng Z, Yang H, Li Z, He X, Griffith CC, Chen X, Guo X, Zheng B, Wu S, Zhao C: Prevalence and Genotype Distribution of HPV Infection in China: Analysis of 51,345
HPV Genotyping Results from China's Largest CAP Certified Laboratory. Journal of Cancer 2016, 7(9):1037-1043.
10.Zhang R, Velicer C, Chen W, Liaw KL, Wu EQ, Liu B, Cui JF, Belinson JL, Zhang X, Shen
GH: Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grades
1 or worse among 4215 Chinese women in a population-based study. Cancer Epidemiology 2013, 37(6):939-945.
11.Wang R, Guo XL, Wisman GB, Schuuring E, Wang WF, Zeng ZY, Zhu H, Wu SW: Nationwide prevalence of human papillomavirus infection and viral genotype distribution
in 37 cities in China. Bmc Infectious Diseases 2015, 15(1):257.
12.Zheng LB, Li YL, Lu SH, Bao JP, Yang W, Zhang XR, Hong X, Rong WG: Physical characteristics of Chinese Hakka. Science China-life Sciences 2013, 56(6):541-551.
13.Zhao P, Liu S, Zhong Z, Hou J, Lin L, Weng R, Su L, Lei N, Hou T, Yang H: Prevalence and genotype distribution of human papillomavirus infection among women
in northeastern Guangdong Province of China. Bmc Infectious Diseases 2018, 18(1):204.
14.Giuliano AR, Kreimer AR, Silvia DS: The beginning of the end: vaccine prevention of HPV-driven cancers. Journal of the National Cancer Institute 2015, 107(6):djv128.
15.Burchell AN, Winer RL, Sanjosé SD, Franco EL: Chapter 6: Epidemiology and transmission dynamics of genital HPV infection. Vaccine 2006, 24(1):S52-S61.
16.Wei W, Shi Q, Guo F, Zhang BY, Chen C, Zhang NS, Dong XP: The distribution of human papillomavirus in tissues from patients with head and neck
squamous cell carcinoma. Oncology Reports 2012, 28(5):1750-1756.
17.Yukari A, Rika KM, Fumihiko T, Asami U, Kazunari K, Hajime T, Kazunori N, Kei K, Tohru
M, Takashi I: Human papillomavirus genotype distribution in cervical intraepithelial neoplasia grade
2/3 and invasive cervical cancer in Japanese women. Japanese Journal of Clinical Oncology 2014, 44(10):910-917.
18.Zhao F, Nan LI, Junfei MA: Study of the association between human papillomavirus infection and cervical cancer
in Xiangyuan county, Shanxi province. Chinese Journal of Epidemiology 2001, 22(5):375-378.
19.Linqian W, Baiping W, Junjun L, Liyu C: Prevalence of human papillomavirus and its genotype among 1336 invasive cervical cancer
patients in Hunan province, central south China. Journal of Medical Virology 2015, 87(3):516-521.
20.Elizabeth Louise D, Rachel Isaksson V, Bliss RL, Downs LS: Multiple-type human papillomavirus (HPV) infections: a cross-sectional analysis of
the prevalence of specific types in 309,000 women referred for HPV testing at the
time of cervical cytology. International Journal of Gynecological Cancer 2013, 23(7):1295-1302.
21.Fife KH, Cramer HM, Schroeder JM, Brown DR: Detection of multiple human papillomavirus types in the lower genital tract correlates
with cervical dysplasia. Journal of Medical Virology 2001, 64(4):550–559.
22.Hee Jung A, Nam Hoon C, Young LS, In Ho K, Chan L, Seung Jo K, Sook MM, Se Hyun K,
Jeongmi Kim J: Correlation of cervical carcinoma and precancerous lesions with human papillomavirus
(HPV) genotypes detected with the HPV DNA chip microarray method. Cancer 2010, 97(7):1672-1680.
23.Shiho M, Koji M, Akinori O, Toyomi S, Hajime T, Toshiharu Y, Yuji T, Hiroyuki Y: Do we need a different strategy for HPV screening and vaccination in East Asia? International Journal of Cancer 2010, 119(11):2713-2715.
24.Xiurong D, Zhizhong L, Jianrong S, Donghui Y, Wei S, Zhaoying Z: Human papillomavirus type-specific prevalence in women referred for colposcopic examination
in Beijing. Journal of Medical Virology 2015, 86(11):1937-1943.
25.Jun CH, Lee AH, Linda C, Binns CW, Daniel X: A review of dietary prevention of human papillomavirus-related infection of the cervix
and cervical intraepithelial neoplasia. Nutrition & Cancer-an International Journal 2013, 65(3):317-328.
26.Zeng XX, Yan LX, Huang XX, He CH, Liu WG, Yuan WQ, Qiu YP, Liu ZX: Prevalence and genotype distribution of human papillomavirus among Hakka women in
China. Ann Transl Med 2016, 4(15):276.
27.Koji M, Akinori O, Reiko F, Hiroo M, Toshiharu Y, Naoyoshi T, Akira M, Takuma F, Yasuo
H, Tsuyoshi I: Predicting the progression of cervical precursor lesions by human papillomavirus genotyping:
a prospective cohort study. International Journal of Cancer 2011, 128(12):2898-2910.